InvestorsHub Logo
Followers 9
Posts 849
Boards Moderated 0
Alias Born 01/06/2007

Re: None

Thursday, 08/27/2020 11:34:52 AM

Thursday, August 27, 2020 11:34:52 AM

Post# of 1765
We might be anticipating maybe the end
HOFFMAN ESTATES, IL, Nov. 27, 2018 (NewMediaWire) -- Wellness Center USA, Inc. (OTCQB: WCUI) and Psoria-Shield, Inc. (PSI) today announced the formation of a Joint Venture between Psoria-Shield, Inc and PSI Gen 2 Funding, Inc. (“GEN2”), to further development of their next generation phototherapy device. The Joint Venture will be conducted through Neo Phototherapy, LLC (“NEO”), a recently formed Illinois limited liability company.

The next generation Class II medical device is the result of 24 months of product R&D and market research based on the previous Psoria-Light (“PL 1000”) and will utilize a new custom LED emitter array, operate on a new native software platform, use current SOTA high efficient microprocessor systems, and will be smaller, lighter, quieter, and more efficient than the current PL 1000 device.

The unique LED technology in development will allow NEO to provide clinicians with a compact, easy to use, light weight and portable UVA-UVB emitting device (approx. 8.5 lbs). Phototherapy treatment is expected to expand significantly beyond the current 16,000 dermatologists to the more than 327,000 general practice and internal medicine physicians, who previously did not treat patients, but referred them to specialists. Besides treating psoriasis, eczema, and vitiligo, the next generation device is designed to be expandable to include added LED wavelengths for additional treatment applications for other medical and cosmetic conditio